Mitoxantrone,  a multiple sclerosis (MS)  drug that is already associated with a higher risk for leukemia and heart damage, may also raise a person’s risk of colorectal cancer, researchers at the University of Würzburg, in Germany, reported. If confirmed in larger studies, the findings indicate that colonoscopies should be conducted on MS patients after…
mitoxantrone
New research from Italy and Spain demonstrated that intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) was better than the medication mitoxantrone in treating severe cases of multiple sclerosis. The study appeared in the February 11, 2015, online issue of Neurology.  MS is characterized by an immune system attack on the…
Recommended Posts
- Disrupted brain blood flow tied to poorer cognitive function in MS
- FDA grants priority review to ‘high-efficacy’ drug for 2 types of MS
- More than 3 million people living with MS globally, report shows
- Learning to listen as I wage a never-ending, silent battle with chronic pain
- Experimental therapy K-9 restores lost vision and mobility in MS mice